Cancer vaccines in hematologic malignancy: A systematic review of the rational and evidence for clinical use
{{output}}
Immunotherapy, including immune checkpoint blockade, CART cells and bispecific antibodies have resulted in dramatic improvements in outcomes for patients with hematological malignancies, demonstrating the unique potency of the immune system in targeting malign... ...
